SCHEMBL3723299

SCHEMBL3723299

CC(=O)Oc1ccc(NC(=O)N2CCN(c3ccccc3C(C)(C)C)CC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 7/20 0.74
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
TRPV1 Q8NER1 3/20 0.54
CA2 P00918 3/20 0.53
CA9 Q16790 3/20 0.53
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.49
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
STS P08842 1/20 0.48
GOT1 P17174 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3723297 0.89 RBP4 (0.71) RBP4MEN1KMT2ATRPV1CA2
SCHEMBL30996953 0.86 RBP4 (1.00) RBP4MEN1KMT2ATRPV1POLB
SCHEMBL630718 0.86 RBP4 (1.00) RBP4MEN1KMT2ATRPV1POLB
SCHEMBL631664 0.85 RBP4 (0.83) RBP4MEN1KMT2ATRPV1CA2
SCHEMBL766225 0.84 RBP4 (0.73) RBP4MEN1KMT2ATRPV1CA2
SCHEMBL766179 0.83 RBP4 (0.72) RBP4MEN1KMT2ATRPV1CA2
SCHEMBL631074 0.83 RBP4 (0.69) RBP4MEN1KMT2ATRPV1CA2
SCHEMBL630971 0.83 RBP4 (0.72) RBP4MEN1KMT2ATRPV1CA2
SCHEMBL3718602 0.83 RBP4 (0.72) RBP4MEN1KMT2APOLBMAPT
SCHEMBL27873728 0.82 RBP4 (0.67) RBP4MEN1KMT2ATRPV1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102459209-A Derivatives of N-acyl-N' -phenylpiperazines for the prevention or treatment of diabetes (etc.) TAKEDA PHARMACEUTICAL 2012-05-16 CN disclosed
WO-2010119992-A1 DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-10-21 WO disclosed